Ovid Therapeutics Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Ovid Therapeutics (OVID) IPO Opens 7% Lower
May 5, 2017 10:43 AM EDTToday's IPO for Ovid Therapeutics (NASDAQ: OVID) opened for trading at $14 after pricing 5,000,000 shares of its common stock at a public offering price of $15.00 per share.
In addition, Ovid Therapeutics has granted the underwriters a 30-day option to purchase up to 750,000... More
